Carnations may seem difficult to draw but they are actually really simple! Draw along with me as we work through these ...

Learn to draw an iris fast! This flower might seem intimidating, but once you understand its petal structure, the form of the iris is a lot of fun to illustrate. Subscribe to my channel so you never ...

Use slow-release fertilizer. A steady, slow supply of nutrients will encourage reblooming roses to set more flowers. Scatter ...

These easy DIY Mother's Day crafts include ideas for all ages from preschoolers to teens, plus projects kids and adults can ...

Marco Rose has been shown the door by RB Leipzig ... He said after the 2-2 draw that sent his side crashing out of the competition: “Atmosphere makes football. We had to adopt the mood ...

Head coach John Mitchell makes 13 changes as England look for second win of 2025 Women's Six Nations; Red Roses began campaign with 38-5 victory over Italy on Sunday; defending champions seek ...

This is a unique opportunity to attract some of our best STEM talent back to India and plug them into the new research, development, and innovation opportunities that will be opened by the big thrust ...

World No. 1 Nelly Korda and young phenom Rose Zhang are back playing on the LPGA this week in Arizona. Korda spent the last month off, resting, training, and hanging out with family at home.

But then a ground-breaking experiment with actress Rose Ayling-Ellis at the helm has changed everything for them. Not only have the OAPs’ opinions of themselves rapidly shifted, but their recent ...

After several weeks of rumours, Concord has confirmed that it is acquiring music distributor and financial-tech firm Stem. While Concord did not disclose how much it is paying for Stem, speculation ...

"With Concord's backing, we gain more fuel for the engine and a global team to help us scale," says Stem's CEO. By Elizabeth Dilts Marshall Nashville-based publishing and catalog giant Concord ...

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal-cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial ...